Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H17Cl2N |
| Molecular Weight | 306.23 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H]1CC[C@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
InChI
InChIKey=VGKDLMBJGBXTGI-SJKOYZFVSA-N
InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m1/s1
cis-(-)-Sertraline (aka 1R,4R-sertraline) is the therapeutically inactive enantiomer of Sertraline. Sertraline has four stereoisomers: (1R,4R), (1S,4S), (1R,4S), and (1S,4R), of which the (1S,4S) isomer is the active therapeutic compound. Sertraline is sold under the brand name Zoloft (and others) as an anti-depressant acting as a selective serotonin reuptake inhibitor. The bio-activity of sertraline is restricted to (1S,4S), and (1R,4R), where (1S,4S) is most potent.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID401036448
Created by
admin on Sat Dec 16 07:58:29 GMT 2023 , Edited by admin on Sat Dec 16 07:58:29 GMT 2023
|
PRIMARY | |||
|
79617-98-4
Created by
admin on Sat Dec 16 07:58:29 GMT 2023 , Edited by admin on Sat Dec 16 07:58:29 GMT 2023
|
PRIMARY | |||
|
54375
Created by
admin on Sat Dec 16 07:58:29 GMT 2023 , Edited by admin on Sat Dec 16 07:58:29 GMT 2023
|
PRIMARY | |||
|
CVO48CMI7U
Created by
admin on Sat Dec 16 07:58:29 GMT 2023 , Edited by admin on Sat Dec 16 07:58:29 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
